Literature DB >> 11298293

Transforming growth factor-beta suppresses interferon-gamma-induced toxoplasmastatic activity in murine macrophages by inhibition of tumour necrosis factor-alpha production.

J A Langermans1, P H Nibbering, M E Van Vuren-Van Der Hulst, R Van Furth.   

Abstract

Activation of macrophages plays an important role in the host resistance against intracellular pathogens. Various mechanisms are employed to control the activation processes and limit tissue damage by factors produced by activated macrophages. One of these mechanisms is the production of macrophage-deactivating cytokines, such as tumour growth factor (TGF)-beta. The present study concerns the effects of TGF-beta on interferon (IFN)-gamma-induced activation of murine macrophages with respect to induction of toxoplasmastatic activity, and production of tumour necrosis factor (TNF)-alpha, prostaglandin E2 (PGE2) and reactive nitrogen intermediates (RNI). IFN-gamma activation of macrophages resulted in inhibition of T. gondii proliferation [mean fold increase (FI) = 1.8, control mean FI = 7.0]; polymyxin B had no effect on this activation. The IFN-gamma-induced toxoplasmastatic activity of macrophages was inhibited by TGF-beta (mean FI = 6.3), which was also found for the IFN-gamma-induced production of TNF-alpha, RNI and PGE2 by macrophages. We found that PGE2, which has macrophage deactivating properties, was not involved in the inhibition of macrophage activation by TGF-beta. The deactivating activities of TGF-beta on the IFN-gamma-induced toxoplasmastatic activity and production of RNI are mediated by inhibition of production of TNF-alpha. Addition of exogenous TNF-alpha during the incubation of macrophages with IFN-gamma and TGF-beta abrogated the deactivating activity of TGF-beta. In sum, the results demonstrate that inhibition of TNF-alpha production is a key factor in the TGF-beta-induced suppression of macrophage activation with respect to toxoplasmastatic activity and RNI production.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11298293     DOI: 10.1046/j.1365-3024.2001.00371.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  10 in total

Review 1.  Subversion of innate and adaptive immune responses by Toxoplasma gondii.

Authors:  Christine Lang; Uwe Gross; Carsten G K Lüder
Journal:  Parasitol Res       Date:  2006-10-06       Impact factor: 2.289

2.  Suppressed production of pro-inflammatory cytokines by LPS-activated macrophages after treatment with Toxoplasma gondii lysate.

Authors:  Eun-Jung Lee; Yoo-Mi Heo; Jong-Hak Choi; Hyun-Ouk Song; Jae-Sook Ryu; Myoung-Hee Ahn
Journal:  Korean J Parasitol       Date:  2008-09       Impact factor: 1.341

3.  Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and exacerbated by anti-transforming growth factor beta antibodies.

Authors:  Ching Li; Latifu A Sanni; Fakhreldin Omer; Eleanor Riley; Jean Langhorne
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

4.  BeWo trophoblast cell susceptibility to Toxoplasma gondii is increased by interferon-gamma, interleukin-10 and transforming growth factor-beta1.

Authors:  B F Barbosa; D A O Silva; I N Costa; J R Mineo; E A V Ferro
Journal:  Clin Exp Immunol       Date:  2008-03       Impact factor: 4.330

5.  Toxoplasma gondii induces prostaglandin E2 synthesis in macrophages via signal pathways for calcium-dependent arachidonic acid production and PKC-dependent induction of cyclooxygenase-2.

Authors:  Bi-Wen Peng; Jian-yin Lin; Tao Zhang
Journal:  Parasitol Res       Date:  2008-02-28       Impact factor: 2.289

6.  Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma.

Authors:  Sheng-Tan Wang; Juan-Juan Liu; Chang-Zhi Wang; Bei Lin; Ying-Ying Hao; Yi-Fei Wang; Song Gao; Yue Qi; Shu-Lan Zhang; Masao Iwamori
Journal:  Oncol Rep       Date:  2011-12-01       Impact factor: 3.906

7.  Deletion of TGF-β1 Increases Bacterial Clearance by Cytotoxic T Cells in a Tuberculosis Granuloma Model.

Authors:  Hayley C Warsinske; Elsje Pienaar; Jennifer J Linderman; Joshua T Mattila; Denise E Kirschner
Journal:  Front Immunol       Date:  2017-12-20       Impact factor: 7.561

Review 8.  Immune response against toxoplasmosis-some recent updates RH: Toxoplasma gondii immune response.

Authors:  Madiha Sana; Muhammad Rashid; Imran Rashid; Haroon Akbar; Jorge E Gomez-Marin; Isabelle Dimier-Poisson
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

9.  Toxoplasma gondii infection induces suppression in a mouse model of allergic airway inflammation.

Authors:  Ignacio M Fenoy; Romina Chiurazzi; Vanesa R Sánchez; Mariana A Argenziano; Ariadna Soto; Mariano S Picchio; Valentina Martin; Alejandra Goldman
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

10.  Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha.

Authors:  Shuai Wang; YuJian Wang; XiaoNi Sun; ZhenChao Zhang; TingQi Liu; Javaid Ali Gadahi; Ibrahim Adam Hassan; LiXin Xu; RuoFeng Yan; XiaoKai Song; XiangRui Li
Journal:  BMC Infect Dis       Date:  2015-10-24       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.